Kostantinos Morris

Dr. Larry Einhorn - Platinum Anniversary Celebration youtu.be/pCRQ-zLSxeo?si… via @YouTube Been at IU for nearly 20 years and this video from the 1st testicular cancer patient to receive the PVB platinum-based regimen still gets me every time!! Revolutionary stuff!!! @04:29

A reminder that we will be having a virtual open house tomorrow, 8/31 at 6PM EST. Come to learn more about this amazing program and our current residents! Zoom link: iu.zoom.us/j/89149406246 #Match2024 #UrologyMatch @UroResidency @Uro_Stream @Uro_Res @Inside_TheMatch

So proud and honored to see our latest work on Prostate Health Index (PHI) in AAM in the May issue @urogoldjournal with cover & tribute to our dear friend and colleague Dr Alan Partin. So fitting but so sad to have lost him so young! @ThomasPolascik @Kost_Morr @DrKotamarti

Kudos to @Kost_Morr @IUuro for great job on our latest work on secondary prostate cancer screening test PHI in AAM @DukeUrology @DukeUroRes @DukeGUCancer authors.elsevier.com/a/1gn~8KZx3c86…

Judd W. Moul, MD, spoke with CancerNetwork® about the latest research from the journal ONCOLOGY® on the treatment of a patients with evidence of prostate cancer despite multiple negative prognostic tests. #pcsm | @JuddMoul @Kost_Morr bit.ly/3x4EKif

The limited utility of #Prostate Health Index in #AfricanAmerican Men with a PSA 4-10. Presentation by @Kost_Morr @DukeMedSchool. #AUA22 written coverage by @MinhChauVuuu @UCI_Urology on UroToday > bit.ly/3NhGivx @JuddMoul @DrKotamarti @AmerUrological

@AmerUrological #AUA22 first podium for @Kost_Morr who did a stellar job with our PHI database and survived questions from moderator Dr Catalona who discovered PHI- is that pressure or what! Great session!

If you're at #AUA22 come check out my podium on 5/13 @ 1:30pm about "Re-thinking How We Use Prostate Health Index for African American Men"

Today on Second Opinion: @JuddMoul discusses with @Kost_Morr the case of a patient who presented with elevated prostate-specific antigen levels & multiple imaging tests that appeared to indicate an absence of malignancy. @CancerNetwrk @byMattHoffman ow.ly/Hpg350ITvJn

@DukeSurgery Research Day: @Kost_Morr presents our ongoing work using Prostate Health Index (PHI) to screen African American men for prostate cancer @DukeGUCancer @DukeCancer @DukeMedSchool Great job @IUuro getting a rising ⭐️

Dr. Judd W. Moul, MD, and colleagues present the case of a man, aged 73 years, with a prostate-specific antigen level of 110 ng/mL after 4 negative prostate biopsies and 4 negative prostate MRIs. #pcsm | @JuddMoul @Kost_Morr ow.ly/jRM750ImaJi

Special kudos to @DukeMedSchool MS4 Kosta Morris @Kost_Morr and my @DukeRadiology colleague @RajanTGuptaMD & @DukePathDept Dr Avani Pendse & @DukeUroRes @DominicGrimberg for great case!

We could not be more excited to match Ginnie, Kostantinos, Will, and Leo to our program! Congratulations to these future IU Urologists. Sunglasses to come because the future is bright! #AUAMatch #uromatch @AmerUrological

Congrats to my @DukeMedSchool colleague @Kost_Morr for matching at @UrologyofIN urology. But, I told him not to let it go to his head because we still have papers to write! Today though is all about celebrating our new future urologists! @DukeUrology @DukeUroRes

Kudos to @Kost_Morr @DrKotamarti for strong work in having a number of abstracts accepted for #AUA22 related to our work in prostate cancer early detection! We also have an EAU-Amsterdam presentation accepted but concerned about attending in person due to #Omikron surge

A research collaboration between scientists at @Duke and @UNC has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19. corporate.dukehealth.org/news/duke-unc-… @TheDHVI

Financial toxicity in cirrhosis more common in women. See #ACG2021 poster P1797 (S1161) Monday. Congrats to @DukeMedSchool student @Kost_Morr on this important study @AMuir_DukeGI @AmCollegeGastro @Julius__Wilder @GoachPA_DukeGI

This study aimed to compare the same regimens in individuals at moderate to high risk for sepsis undergoing percutaneous nephrolithotomy. bit.ly/3rAZHO4

Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role? bit.ly/38s4xFp

AUA Guideline Part I: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia -- Initial Work-up and Medical Management bit.ly/3CKjEqu